{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:22:29Z","timestamp":1792606949603,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jceh.2025.103114","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:35:30Z","timestamp":1752600930000},"page":"103114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond"],"prefix":"10.1016","volume":"15","author":[{"given":"Eva","family":"Ju\u00e1rez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Berrospe-Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misael","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"L\u00f3pez-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103114_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jceh.2025.103114_bib2","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103114_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100101","article-title":"Combined alcoholic and non-alcoholic steatohepatitis","volume":"2","author":"Ntandja Wandji","year":"2020","journal-title":"JHEP Reports"},{"key":"10.1016\/j.jceh.2025.103114_bib4","first-page":"219","article-title":"Controversies in the diagnosis and management of NAFLD and NASH","volume":"10","author":"Rinella","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","article-title":"Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2025.103114_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","article-title":"MetALD: new opportunities to understand the role of alcohol in steatotic liver disease","volume":"8","author":"Israelsen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib7","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.3390\/ijms21165888","article-title":"History of nonalcoholic fatty liver disease","volume":"21","author":"Lonardo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2025.103114_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jceh.2025.103114_bib9","first-page":"S1542","article-title":"An Expert consensus Delphi panel in metabolic dysfunction- and alcohol-associated liver disease: opportunities and challenges in clinical practice","volume":"30","author":"Diaz","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jhep.2023.11.006","article-title":"Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes","volume":"80","author":"D\u00edaz","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib11","series-title":"Global Status Report on Alcohol and Health and Treatment of Substance Use Disorders","year":"2018"},{"key":"10.1016\/j.jceh.2025.103114_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/YCO.0000000000000422","article-title":"Alcohol drinking and problems in young populations","volume":"31","author":"Wang","year":"2018","journal-title":"Curr Opin Psychiatr"},{"key":"10.1016\/j.jceh.2025.103114_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib14","series-title":"Informe Sobre La Situaci\u00f3n Del Alcohol y La Salud En La Regi\u00f3n de Las Am\u00e9ricas 2020","year":"2021"},{"key":"10.1016\/j.jceh.2025.103114_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4162\/nrp.2022.16.3.392","article-title":"Association between drinking behaviors and components of metabolic syndrome in subjects in their 20s and 30s: data obtained from the Korea National Health and Nutrition Examination Survey (2016\u20132018)","volume":"16","author":"Lee","year":"2022","journal-title":"Nutr Res Prac"},{"key":"10.1016\/j.jceh.2025.103114_bib16","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.3390\/ijms22105170","article-title":"Alcohol-related liver disease: basic mechanisms and clinical perspectives","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2025.103114_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/ip.8.3.221","article-title":"Drinking histories of fatally injured drivers","volume":"8","author":"Baker","year":"2002","journal-title":"Inj Prev"},{"key":"10.1016\/j.jceh.2025.103114_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/acer.14271","article-title":"Interaction between alcohol use and metabolic risk factors for liver disease: a critical review of epidemiological studies","volume":"44","author":"\u00c5berg","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2025.103114_bib20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/liv.13408","article-title":"Binge drinking and the risk of liver events: a population-based cohort study","volume":"37","author":"\u00c5berg","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103114_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000450","article-title":"A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis","volume":"8","author":"Babuta","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2025.103114_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/00365520802555991","article-title":"Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease","volume":"44","author":"Ekstedt","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103114_bib23","article-title":"Association between alcohol consumption and hepatic fibrosis in Chinese adult males with metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Li","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.jceh.2025.103114_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1471-2407-11-446","article-title":"How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature","volume":"11","author":"Heckley","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jceh.2025.103114_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3350\/cmh.2024.0631","article-title":"Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations","volume":"31","author":"Danpanichkul","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib26","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/nu15132856","article-title":"Metabolic and risk profiles of lean and non-lean hepatic steatosis among US adults","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2025.103114_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: Expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"issue":"suppl l","key":"10.1016\/j.jceh.2025.103114_bib28","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.3350\/cmh.2022.0393","article-title":"The effects of moderate alcohol consumption on non-alcoholic fatty liver disease","volume":"29","author":"Oh","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ueg2.12524","article-title":"Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease","volume":"12","author":"Hagstr\u00f6m","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jceh.2025.103114_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101127","article-title":"Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score","volume":"6","author":"Sripongpun","year":"2024","journal-title":"JHEP Reports"},{"key":"10.1016\/j.jceh.2025.103114_bib31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103114_bib32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017\u20132020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib33","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.cgh.2024.05.030","article-title":"Prevalence of steatotic liver disease subtypes and association with metabolic risk factors in the Framingham heart study","volume":"22","author":"Sun","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib34","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents","volume":"14","author":"Shi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2025.103114_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41575-024-01022-y","article-title":"The steatotic liver disease burden paradox: unravelling the key role of alcohol","volume":"22","author":"Torp","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119161","article-title":"Liver and atherosclerotic risk of alcohol consumption in patients with metabolic dysfunction-associated Steatotic Liver Disease","volume":"403","author":"Wang","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jceh.2025.103114_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156306","article-title":"Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes","author":"Cuthbertson","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2025.103114_bib38","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/apt.18286","article-title":"Metabolic dysfunction-associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: a nationwide cohort study","volume":"60","author":"Park","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2025.103114_bib39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.32642","article-title":"Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality","volume":"77","author":"van Kleef","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103114_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4093\/dmj.2024.0042","article-title":"Metabolic dysfunction-associated steatotic liver disease and all-cause and cause-specific mortality","volume":"49","author":"Oh","year":"2025","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jceh.2025.103114_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jhep.2024.05.042","article-title":"Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort","volume":"81","author":"Oh","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib42","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.3390\/nu14163266","article-title":"Association between alcohol consumption and the risk of sarcopenia: a systematic review and meta-analysis","volume":"14","author":"Hong","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2025.103114_bib43","doi-asserted-by":"crossref","first-page":"c1240","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"Hart","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2025.103114_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/S0618-8278(19)30247-6","article-title":"In NAFLD, alcohol drinking habits and genetics predict progression to advanced liver disease: follow-up of population surveys","author":"\u00c5berg","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","article-title":"Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK","volume":"55","author":"Xu","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib46","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.3390\/ijms24097791","article-title":"Fatty liver disease, metabolism and alcohol interplay: a comprehensive review","volume":"24","author":"Odriozola","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2025.103114_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103114_bib48","first-page":"313","article-title":"Liver health and the interplay between obesity, alcohol and bariatric surgery","volume":"86","author":"Geerts","year":"2023","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jceh.2025.103114_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/nutrit\/nuab031","article-title":"The interplay of Western diet and binge drinking on the onset, progression, and outlook of liver disease","volume":"80","author":"Chris Skinner","year":"2022","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jceh.2025.103114_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4162\/nrp.2018.12.2.166","article-title":"Relationship between heavy drinking, binge drinking, and metabolic syndrome in obese and non-obese Korean male adults","volume":"12","author":"Oh","year":"2018","journal-title":"Nutr Res Prac"},{"key":"10.1016\/j.jceh.2025.103114_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281954","article-title":"Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism","volume":"18","author":"Buyco","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103114_bib52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0040-1701443","article-title":"Drinking and obesity: alcoholic liver disease\/nonalcoholic fatty liver disease interactions","volume":"40","author":"\u00c5berg","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103114_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0214-9168(06)73708-1","article-title":"Esteatosis hep\u00e1tica y resistencia a la insulina: \u00bfqu\u00e9 ocurre primero?","volume":"18","author":"Esteve-Lafuente","year":"2006","journal-title":"Cl\u00edn Invest Arterioscler"},{"key":"10.1016\/j.jceh.2025.103114_bib54","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103114_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001629","article-title":"Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study","volume":"8","author":"Okamura","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jceh.2025.103114_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3849","article-title":"Association of habitual alcohol intake with risk of cardiovascular disease","volume":"5","author":"Biddinger","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jceh.2025.103114_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005123","article-title":"Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action","volume":"5","author":"Lindtner","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jceh.2025.103114_bib58","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3390\/ijerph19094941","article-title":"Risk of hypertension and type 2 diabetes in relation to changes in alcohol consumption: a nationwide cohort study","volume":"19","author":"Choi","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.jceh.2025.103114_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12876-025-03661-0","article-title":"Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study","volume":"25","author":"Liang","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103114_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/17474124.2020.1757427","article-title":"Sarcopenia in chronic liver diseases: a translational overview","volume":"14","author":"Barbero-Becerra","year":"2020","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib61","article-title":"Alcohol and skeletal muscle in health and disease","volume":"43","author":"Simon","year":"2023","journal-title":"Alcohol Res"},{"key":"10.1016\/j.jceh.2025.103114_bib62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/mus.20168","article-title":"Effects of alcohol on skeletal and cardiac muscle","volume":"30","author":"Urbano-M\u00e1rquez","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jceh.2025.103114_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsams.2008.12.627","article-title":"Acute alcohol consumption aggravates the decline in muscle performance following strenuous eccentric exercise","volume":"13","author":"Barnes","year":"2010","journal-title":"J Sci Med Sport"},{"key":"10.1016\/j.jceh.2025.103114_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.11005\/jbm.2021.28.1.41","article-title":"The association between alcohol consumption and grip strength in a nationwide survey","volume":"28","author":"Lee","year":"2021","journal-title":"J Bone Metab"},{"key":"10.1016\/j.jceh.2025.103114_bib65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1468-1331.2001.00303.x","article-title":"Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis","volume":"8","author":"Preedy","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jceh.2025.103114_bib66","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1186\/s12889-022-14275-6","article-title":"Alcohol consumption patterns and the risk of sarcopenia: a population-based cross-sectional study among Chinese women and men from Henan province","volume":"22","author":"Zhai","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jceh.2025.103114_bib67","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/GME.0000000000000879","article-title":"Associations between high-risk alcohol consumption and sarcopenia among postmenopausal women","volume":"24","author":"Kwon","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.jceh.2025.103114_bib68","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00952990.2023.2300049","article-title":"The association of alcohol consumption with the risk of sarcopenia: a dose-response meta-analysis","volume":"50","author":"Bu","year":"2024","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jceh.2025.103114_bib69","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1053\/j.gastro.2020.02.033","article-title":"TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits \u03b3-butyrobetaine hydroxylase, and exacerbates fatty liver in mice","volume":"158","author":"Zhao","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103114_bib70","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103114_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut","volume":"590","author":"Seki","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.jceh.2025.103114_bib72","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103114_bib73","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2025.103114_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.rgmx.2023.01.002","article-title":"Desregulaci\u00f3n inmunol\u00f3gica y fisiopatolog\u00eda del consumo de alcohol y la enfermedad hep\u00e1tica alcoh\u00f3lica","volume":"88","author":"Martinez-Castillo","year":"2023","journal-title":"Rev Gastroenterol M\u00e9xico"},{"key":"10.1016\/j.jceh.2025.103114_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jceh.2025.103114_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib77","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","article-title":"Alcohol-related liver disease: clinical practice guidelines by the Latin American association for the study of the liver (ALEH)","volume":"18","author":"Arab","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0044-1785228","article-title":"Is there a safe alcohol consumption limit for the general population and in patients with liver disease?","volume":"44","author":"Romero-G\u00f3mez","year":"2024","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2025.103114_bib79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13148-021-01186-3","article-title":"Validating biomarkers and models for epigenetic inference of alcohol consumption from blood","volume":"13","author":"Maas","year":"2021","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.jceh.2025.103114_bib80","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism. The CAGE questionnaire","volume":"252","author":"Ewing","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2025.103114_bib81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.1993.tb00822.x","article-title":"Alcohol consumption and related problems among primary health care patients: WHO collaborative project on early detection of persons with harmful alcohol consumption--I","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.jceh.2025.103114_bib82","first-page":"11","article-title":"Validation of the alcohol use disorders identification test (AUDIT) in primary care","volume":"198","author":"Rubio","year":"1998","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.jceh.2025.103114_bib83","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/00952990.2018.1456545","article-title":"A review of the alcohol use disorders identification test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions","volume":"44","author":"Higgins-Biddle","year":"2018","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.jceh.2025.103114_bib84","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/dar.13534","article-title":"Prevalence of alcohol consumption in emergency presentations: novel approach using two biomarkers, ethanol and phosphatidylethanol","volume":"42","author":"Cameron","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"18","key":"10.1016\/j.jceh.2025.103114_bib85","first-page":"309","article-title":"Alcohol biomarkers in clinical and forensic contexts","volume":"115","author":"Andresen-Streichert","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jceh.2025.103114_bib86","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib87","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103114_bib88","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2025.103114_bib89","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1017\/neu.2025.6","article-title":"A systematic review on the role of glucagon-like peptide-1 receptor agonists on alcohol-related behaviors: potential therapeutic strategy for alcohol use disorder","volume":"37","author":"Zheng","year":"2025","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.jceh.2025.103114_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.102509","article-title":"Naltrexone for alcohol use disorder in cirrhosis: bridging the gap in an understudied population","volume":"15","author":"Vergara-Quispe","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib91","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms","volume":"180","author":"Anton","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jceh.2025.103114_bib92","article-title":"Baclofen for alcohol use disorder","volume":"2023","author":"Agabio","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2025.103114_bib93","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2018.10.041","article-title":"Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study","volume":"70","author":"Thursz","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib94","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.numecd.2024.05.018","article-title":"Impacts of cardiometabolic risk factors and alcohol consumption on all-cause mortality among MASLD and its subgroups","volume":"34","author":"Li","year":"2024","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.jceh.2025.103114_bib95","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103114_bib96","doi-asserted-by":"crossref","first-page":"876","DOI":"10.14309\/ajg.0000000000000607","article-title":"Light-to-Moderate alcohol consumption is associated with increased risk of type 2 diabetes in individuals with nonalcoholic fatty liver disease: a nine-year cohort study","volume":"115","author":"Xu","year":"2020","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:13:56Z","timestamp":1763399636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325006140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0973688325006140"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103114","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103114"}}